Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 5
2018 4
2019 1
2020 11
2021 33
2022 66
2023 81
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy.
Klemm J, Shariat SF, Laukhtina E, Rajwa P, Vetterlein MW, Schuettfort VM, von Deimling M, Dahlem R, Fisch M, Rink M. Klemm J, et al. Among authors: rajwa p. Clin Genitourin Cancer. 2024 Mar 21:102079. doi: 10.1016/j.clgc.2024.102079. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38614853
Predictive Models for Assessing Patients' Response to Treatment in Metastatic Prostate Cancer: A Systematic Review.
Lawlor A, Lin C, Gómez Rivas J, Ibáñez L, Abad López P, Willemse PP, Imran Omar M, Remmers S, Cornford P, Rajwa P, Nicoletti R, Gandaglia G, Yuen-Chun Teoh J, Moreno Sierra J, Golozar A, Bjartell A, Evans-Axelsson S, N'Dow J, Zong J, Ribal MJ, Roobol MJ, Van Hemelrijck M, Beyer K; PIONEER Consortium. Lawlor A, et al. Among authors: rajwa p. Eur Urol Open Sci. 2024 Apr 4;63:126-135. doi: 10.1016/j.euros.2024.03.012. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38596781 Free PMC article. Review.
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis.
Matsukawa A, Rajwa P, Kawada T, Bekku K, Laukhtina E, Klemm J, Pradere B, Mori K, Karakiewicz PI, Kimura T, Chlosta P, Shariat SF, Yanagisawa T. Matsukawa A, et al. Among authors: rajwa p. Int J Clin Oncol. 2024 Apr 6. doi: 10.1007/s10147-024-02485-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38582807 Review.
Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis.
Fazekas T, Shim SR, Basile G, Baboudjian M, Kói T, Przydacz M, Abufaraj M, Ploussard G, Kasivisvanathan V, Rivas JG, Gandaglia G, Szarvas T, Schoots IG, van den Bergh RCN, Leapman MS, Nyirády P, Shariat SF, Rajwa P. Fazekas T, et al. Among authors: rajwa p. JAMA Oncol. 2024 Apr 5:e240734. doi: 10.1001/jamaoncol.2024.0734. Online ahead of print. JAMA Oncol. 2024. PMID: 38576242
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Rajwa P, Borkowetz A, Abbott T, Alberti A, Bjartell A, Brash JT, Campi R, Chilelli A, Conover M, Constantinovici N, Davies E, De Meulder B, Eid S, Gacci M, Golozar A, Hafeez H, Haque S, Hijazy A, Hulsen T, Josefsson A, Khalid S, Kolde R, Kotik D, Kurki S, Lambrecht M, Leung CH, Moreno J, Nicoletti R, Nieboer D, Oja M, Palanisamy S, Prinsen P, Reich C, Raffaele Resta G, Ribal MJ, Gómez Rivas J, Smith E, Snijder R, Steinbeisser C, Vandenberghe F, Cornford P, Evans-Axelsson S, N'Dow J, Willemse PM. Rajwa P, et al. Eur Urol Open Sci. 2024 Mar 25;63:81-88. doi: 10.1016/j.euros.2024.02.019. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38572301 Free PMC article.
Editorial: Oligometastatic genitourinary cancer.
Rajwa P, Gandaglia G. Rajwa P, et al. Curr Opin Urol. 2024 May 1;34(3):176-177. doi: 10.1097/MOU.0000000000001167. Epub 2024 Apr 4. Curr Opin Urol. 2024. PMID: 38567672 No abstract available.
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics.
Subiela JD, Krajewski W, González-Padilla DA, Laszkiewicz J, Taborda J, Aumatell J, Sanchez Encinas M, Basile G, Moschini M, Caño-Velasco J, Lopez Perez E, Del Olmo Durán P, Gallioli A, Tukiendorf A, D'Andrea D, Yuen-Chun Teoh J, Serna Céspedes A, Pichler R, Afferi L, Del Giudice F, Gomez Rivas J, Albisinni S, Soria F, Ploussard G, Mertens LS, Rajwa P, Laukhtina E, Pradere B, Tully K, Guerrero-Ramos F, Rodríguez-Faba Ó, Alvarez-Maestro M, Dominguez-Escrig JL, Szydełko T, Gomez Dos Santos V, Jiménez Cidre MÁ, Burgos Revilla FJ; European Association of Urology-Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group. Subiela JD, et al. Among authors: rajwa p. Eur Urol Oncol. 2024 Feb 13:S2588-9311(24)00043-9. doi: 10.1016/j.euo.2024.01.017. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38355375
184 results